InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,691.39
(
-0.32%
)
US TECH 100
19,232.80
(
-0.23%
)
Dow Jones
41,962.47
(
-0.55%
)
Brent Oil
77.56
(
3.94%
)
Bitcoin
60,670.42
(
0.08%
)
Post# of 253269
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: gdollasign post# 114892

Wednesday, 02/16/2011 2:42:24 PM

Wednesday, February 16, 2011 2:42:24 PM

Post# of 253269

Ariad will be on the market much sooner with much better results



They are going after quite different markets. The Ariad drug is used in a maintenance setting - these guys are going after very late-stage patients.

What is of more interest is that their primary endpoint is survival compared with the normal PFS in this indication. Likely they had no alternative as the trial is open label.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up